1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone

C23H17ClN4O4S — CID 46933378

IUPAC1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone
SMILESO=C(CSc1nc2ccc(Cl)cc2[nH]1)N1N=C(c2ccco2)CC1c1ccc2c(c1)OCO2
InChIInChI=1S/C23H17ClN4O4S/c24-14-4-5-15-16(9-14)26-23(25-15)33-11-22(29)28-18(10-17(27-28)19-2-1-7-30-19)13-3-6-20-21(8-13)32-12-31-20/h1-9,18H,10-12H2,(H,25,26)
InChIKeyMBGHYIKQFATZQG-UHFFFAOYSA-N
MW480.93 g/mol
LogP5.01
Rot. Bonds5

About 1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone

1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone (PubChem CID 46933378) has the molecular formula C23H17ClN4O4S and a molecular weight of 480.93 g/mol. Its IUPAC name is 1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone.

Molecular Properties

Compound Name1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone
PubChem CID46933378
Molecular FormulaC23H17ClN4O4S
Molecular Weight480.93 g/mol
Exact Mass480.07
IUPAC Name1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone
SMILESO=C(CSc1nc2ccc(Cl)cc2[nH]1)N1N=C(c2ccco2)CC1c1ccc2c(c1)OCO2
InChIInChI=1S/C23H17ClN4O4S/c24-14-4-5-15-16(9-14)26-23(25-15)33-11-22(29)28-18(10-17(27-28)19-2-1-7-30-19)13-3-6-20-21(8-13)32-12-31-20/h1-9,18H,10-12H2,(H,25,26)
InChIKeyMBGHYIKQFATZQG-UHFFFAOYSA-N
XLogP5.01
TPSA92.95 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms33
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500480.93
LogP ≤ 55.01
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze 1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone?
The IUPAC name of 1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone (CID 46933378) is 1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone.
What is the SMILES notation for 1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone?
The canonical SMILES for 1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone is O=C(CSc1nc2ccc(Cl)cc2[nH]1)N1N=C(c2ccco2)CC1c1ccc2c(c1)OCO2.
What is the InChIKey of 1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone?
The InChIKey is MBGHYIKQFATZQG-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H17ClN4O4S/c24-14-4-5-15-16(9-14)26-23(25-15)33-11-22(29)28-18(10-17(27-28)19-2-1-7-30-19)13-3-6-20-21(8-13)32-12-31-20/h1-9,18H,10-12H2,(H,25,26).
What are the key properties of 1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone?
1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone has a molecular weight of 480.93 g/mol, XLogP of 5.01, 5 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-(1,3-benzodioxol-5-yl)-5-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-[(6-chloro-1H-benzimidazol-2-yl)sulfanyl]ethanone is sourced from PubChem (CID 46933378), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).